ABBV Company Financial Information

Symbol Info
AbbVie Inc. (ABBV)
Listed Symbol	ABBV
Name	AbbVie Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share	$3.59
Latest Fiscal Date	2018-12-31
Latest Fiscal Revenue	$32,753,000,000
Latest Fiscal EPS	$3.68
Price Info
21 Day Moving Average	$67.5467
21 Day EMA	$68.112250
50 Day Moving Average	$67.1979
50 Day EMA	$68.445360
200 Day EMA	$75.057430
200 Day Moving Average	76.126350
52 Week High	$96.60
52 Week Low	$62.66
52 Week Change	$-20.985100
Alpha	0.002238
Beta	0.9854
Standard Deviation	0.077512
R2	0.192033
Periods	60
Share Information
10 Day Average Volume	8,620,085
20 Day Average Volume	8,045,743
30 Day Average Volume	8,333,645
50 Day Average Volume	9,341,648
Outstanding Shares	1,478,483,838
Float Shares	1,476,820,991
Percent Float	99.89%
Short Interest	52,536,795
Short Percent Float	3.60%
Short Interest Ratio	6.03
Short Date	2019-08-30
Holders
Institutions	3,021
Institute Holdings Date	2019-08-31
Institute Bought Previous 3 Months	89,414,115
Institute Holdings Percent	-
Institute Sold Previous 3 Months	170,937,377
Insider Holdings Date
Insider Bought Previous 3 Months	-
Insider Holdings Percent	-
Insider Sold Previous 3 Months	-
Insiders Shares Owned	1,662,847
Price Change
7 Day Price Change	$3.4199982
7 Day Percent Change	5.02%
21 Day Price Change	$5.9300003
21 Day Percent Change	9.03%
30 Day Price Change	$7.1699980
30 Day Percent Change	11.13%
Month To Date Price Change	$5.8600
Month To Date Percent	8.91%
90 Day Price Change	$-5.868675
90 Day Percent Change	-7.58%
Quarter To Date	$-0.027748
Quarter To Date Percent	-0.04%
180 Day Price Change	$-7.469925
180 Day Percent Change	-9.45%
200 Day Price Change	$-6.264534
200 Day Percent Change	-8.05%
Year To Date	$-16.93132
Year To Date Percent	-19.12%
Profile
Description	AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.
Details
Issue Type	CS
Market Cap	$104,913,213,144
Sec Type	EQS
Auditor	Ernst & Young LLP
Total Shares Outstanding	1,478,483,838
CEO	Richard A. Gonzalez
Employees	30,000
Last Audit	UE
Classification
CIK	0001551152
Industry	Drug Manufacturers
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)
Info
Address	1 North Waukegan Road North Chicago, IL 60064-6400
Website	http://www.abbvieinvestor.com
Facisimile
Telephone	+1 847 932-7900
Email
Key Ratios
Profitability
EBIT Margin	15.90
EBITDA Margin	21.7
Pre-Tax Profit Margin	23.0
Profit Margin Cont	12.92
Gross Margin	77.40
Profit Margin TOT	12.92
Income Statements
Revenue	$32,624,000,000
Revenue Per Share	$22.0659
Revenue 3 Years	$9.07
Revenue 5 Years	$11.05
Valuation Measures
PE Ratio	25.00
Enterprise Value	$104,576,389,286
Price To Sales	3.244833
Price To Free Cash	17.700000
PE High Last 5 Years	65.1
Price To Book	39.3
Price To Cash Flow	7.9
PE Low Last 5 Years	16.3
Price To Tangible Book	-2.3
Financial Strength
Total Debt To Equity	-
Int Coverage	3.6
Current Ratio	0.9
Leverage Ratio	-8.6
Quick Ratio	0.6
Long Term Debt To Capital	-
Assets
Receivables Turnover	6.3
Invoice Turnover	4.30
Assets Turnover	0.50
Management Effectiveness
Return Assets	6.98
Return On Equity	-69.05
Return On Capital	-
Dividends
Dividend 3 Years	$19.82
Dividend 5 Years	$18.08
Ex Dividend Date	2019-10-11 00:00:00.0
Dividend Rate	$4.28
Dividend Yield	5.98%
Payment Type	Cash